Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

8.35
-0.3000-3.47%
Volume:281.41K
Turnover:2.38M
Market Cap:383.24M
PE:-3.52
High:8.89
Open:8.71
Low:8.34
Close:8.65
52wk High:25.96
52wk Low:4.68
Shares:45.90M
Float Shares:37.58M
Volume Ratio:0.96
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3710
EPS(LYR):-2.2432
ROE:-28.21%
ROA:-18.47%
PB:1.02
PE(LYR):-3.72

Loading ...

BioAge Labs Shareholders Reelect Directors, Ratify Auditor

TIPRANKS
·
Jun 12

BioAge Labs shareholders re-elect three directors at annual meeting

Reuters
·
Jun 12

BioAge Labs posts preclinical data on oral NLRP3 inhibitor BGE-102 in diabetic retinopathy model

Reuters
·
Jun 09

BioAge Labs posts Phase 1 BGE-102 presentation showing anti-inflammatory activity in obesity cohort

Reuters
·
Jun 09

Roth Capital Partners Initiates BioAge Labs at Buy With $36 Price Target

MT Newswires Live
·
May 27

BioAge Labs Initiated at Buy by Roth Capital

Dow Jones
·
May 27

BioAge Labs initiated with a Buy at Roth Capital

TIPRANKS
·
May 27

BioAge Labs joins Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 22

BioAge Labs to Present at Upcoming Investor Conferences

GlobeNewswire
·
May 22

BTIG Initiates BioAge Labs at Buy With $40 Price Target

MT Newswires Live
·
May 13

BioAge Labs Initiated at Buy by BTIG

Dow Jones
·
May 13

BioAge Labs initiated with a Buy at BTIG

TIPRANKS
·
May 13

Earnings Beat: BioAge Labs, Inc. (NASDAQ:BIOA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.
·
May 12

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)

TIPRANKS
·
May 12

BioAge Labs posts R&D Day presentation on BGE-102 program

Reuters
·
May 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)

TIPRANKS
·
May 10

BioAge Labs reports Q1 EPS (52c), consensus (63c)

TIPRANKS
·
May 08

BioAge Labs Reports Q1 GAAP Loss of $0.52 Per Share on $2.8 Million Revenue

Deep News
·
May 08

BioAge Labs Q1 Loss Widens, Collaboration Revenue Rises

MT Newswires Live
·
May 08